Postoperative Nausea and Vomiting
Conditions
Keywords
Postoperative nausea and vomiting, Dexmedetomidine, Dexamethasone, Laparoscopic cholecystectomy, Randomized controlled trial
Brief summary
Postoperative nausea and vomiting (PONV) remains a common and distressing complication after laparoscopic cholecystectomy despite advances in anesthesia. Both dexmedetomidine and dexamethasone have shown antiemetic properties, but their comparative effectiveness is still debated. To compare the efficacy of dexmedetomidine and dexamethasone in preventing PONV in patients undergoing laparoscopic cholecystectomy. This double-blind randomized controlled trial included 68 ASA I-II patients scheduled for elective laparoscopic cholecystectomy. Patients were randomly allocated to receive either intravenous dexmedetomidine (1 μg/kg) or dexamethasone (8 mg) after induction of anesthesia. PONV was assessed using a standardized scoring system on arrival in the PACU and at 4, 12, and 24 hours postoperatively. Ondansetron was administered as rescue antiemetic when required. This study aims to determine the more effective prophylactic agent for PONV, with the goal of improving postoperative comfort and quality of care in patients undergoing laparoscopic surgery in the local population.
Interventions
DRUGDexamedomedine
Intravenous dexmedetomidine administered perioperatively.
DRUGDexamethasone
Intravenous dexamethasone administered perioperatively.
Sponsors
Patel Hospital, Pakistan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Both male and female patients will be included 2. Patient between the age of 18 to 60 years. 3. Patient undergoing elective Laparoscopic Cholecystectomy. 4. Patients with American Society of Anesthesiologists (ASA) physical status I and II.
Exclusion criteria
1. Patient not willing to participate in study. 2. Patients with a history of allergy to dexmedetomidine and dexamethasone. 3. Patients having motion sickness and history of PONV in past anesthesia experience. 4. Patients receiving antiemetic drugs during the last 48 hours before laparoscopic cholecystectomy. 5. Patients with body mass index ≥ 30 kg/m2 6. Patients with emergency laparoscopic cholecystectomy. 7. Laparoscopic cholecystectomy lasts for more than one hour. 8. Laparoscopic cholecystectomy converting to open cholecystectomy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The PONV scores over the 24-hour period | From arrival in the post-anesthesia care unit (0 hours) through 24 hours after surgery, assessed at 0, 4, 12, and 24 hours postoperatively. | PONV will be assessed using the Postoperative Nausea and Vomiting (PONV) Scoring Scale (range: 0-3; higher scores indicate worse outcome, where 0 = no nausea/vomiting and 3 = vomiting ≥3 episodes/day). Assessments will be performed at predefined time points: upon arrival in PACU (0 hours), 4 hours, 12 hours, and 24 hours postoperatively. |
Countries
Pakistan
Outcome results
None listed